Early Access Program for Zolbetuximab

Clinical trial NCT06048081 · AVAILABLE

Trial details

NCT number: NCT06048081
Sponsor: Astellas Pharma Global Development, Inc.
Status: AVAILABLE
Study type: EXPANDED_ACCESS

Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma Cancer Locally Advanced Unresectable Gastric Adenocarcinoma Cancer Metastatic Gastric Adenocarcinoma Cancer Metastatic Gastroesophageal Junction (GEJ) Adenocarcinoma

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.